Verano to Open New MÜV Bradenton Dispensary, Providing Increased Access to Medical Cannabis for FL Patients
- MÜV Bradenton – 75th West, located at the high-traffic intersection of Cortez Road and 75th Street West in Bradenton, is Verano’s 35th MÜV location in Florida, and 83rd operating dispensary  overall.
- Verano plans to open five or more additional Florida dispensaries during the remainder of 2021, including new locations in Tampa, Orange City, Pinellas Park and Hollywood.
- MÜV Bradenton – 75th West is positioned an hour southwest of Tampa on Florida’s Gulf Shore in Bradenton, Manatee County, a popular local tourism destination which sees over three million visitors annually. The intersection where MÜV Bradenton – 75th West sits sees annual average daily traffic of over 20,000 cars, according to the Florida Department of Transportation.
CHICAGO – Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or “the Company”), a leading multi-state cannabis company, today announced the opening of its 35th MÜV Florida dispensary located at 4312 75th Street West in Bradenton. The new dispensary is set to open on Saturday, August 7th at 10:00 a.m. local time.
Verano’s 35th MÜV Dispensary in Florida is located in Bradenton, a growing community with a population currently approaching 60,000. The city is situated along the Manatee River between Sarasota (to the south), St. Petersburg (to the northwest), Tampa Bay (to the northeast), and some of Florida’s most coveted Gulf Coast beaches. MÜV Bradenton – 75th West also sits just outside of Cortez, a historic Gulf Coast fishing village. The area is popular with outdoor enthusiasts and revered as a destination for fishing and diving.
“Our new dispensary in Bradenton is within walking distance to some of the best restaurants, beaches, and sunsets Florida’s Gulf Coast has to offer,” said John Tipton, President of Verano. “We anticipate that our dispensary, with its wide range of premium, award-winning MÜV products and a very knowledgeable staff, will be a welcome addition to the West Bradenton community.”
The newest state-of-the-art MÜV Dispensary will offer an extensive selection of award-winning products including MÜV Wana Soft Chew edibles, chocolates and lozenges, flower, pre-rolls, a wide range of vaporizer pens, metered-dose inhalers, topicals and oral sprays, along with patented encapsulation formulations in MÜV’s EnCaps™ capsules, tinctures, 72-hour transdermal patches and transdermal gels. MÜV also has one of the widest selections of concentrates for patients requesting macro-dosing options.
Patients are encouraged to order at muvfl.com for express pickup or delivery. For more information about the new ADA-compliant Bradenton – 75th West, MÜV Medical Cannabis Dispensary, including hours and available MÜV products, visit muvfl.com.
1 - Total dispensary count includes contribution from a pending acquisition.
Verano is a leading, vertically-integrated, multi-state cannabis operator in the U.S. devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano™, Avexia™, Encore™, and MÜV™. Verano’s portfolio encompasses 14 U.S. states, with active operations in 11, including 10 production facilities comprising approximately 832,000 square feet of cultivation (including a 26,000 sq. ft. facility in Massachusetts nearing completion of construction). Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf™ and MÜV™, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.
Forward Looking Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to statements or information with respect to the Company’s position in the marketplace, the proposed completion or buildout of Company facilities, the Company’s cultivation capacity, the fortification of the Company’s presence in core markets, the possibility of material organic expansion, delivery of shareholder value and the ability to maintain industry-leading margins and add depth to leadership.
Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risk factors discussed in the Company's filings on SEDAR at www.sedar.com.
The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
# # #
Chief Investment Officer
Vice President, Marketing & Communications
Sard Verbinnen & Co.
Gabriella Coffey / Ryan McDougald